Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and agmatine

quinoxalines has been researched along with agmatine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hussain, JF; Kendall, DA; Pinthong, D; Wilson, VG1
Hanmer, C; Kendall, DA; Mason, R; Millns, P; Pinthong, D; Wilson, VG; Wright, IK1
Coupar, IM; Liu, L1
Abe, K; Abe, Y; Saito, H1
Burgdorf, C; Engelhardt, A; Kurz, T; Raasch, W; Richardt, G; Schäfer, U1
Bettio, LE; Gonçalves, FM; Leal, RB; Lopes, MW; Moretti, M; Neis, VB; Ribeiro, CM; Rodrigues, AL; Rosa, PB1

Other Studies

6 other study(ies) available for quinoxalines and agmatine

ArticleYear
Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    British journal of pharmacology, 1995, Volume: 115, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Agmatine; Animals; Binding, Competitive; Brimonidine Tartrate; Cattle; Cerebral Cortex; Clonidine; Dioxanes; Idazoxan; Imidazoles; Lung; Methanol; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha-2; Yohimbine

1995
Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 351, Issue:1

    Topics: Adrenergic alpha-Agonists; Agmatine; Animals; Binding Sites; Binding, Competitive; Brimonidine Tartrate; Clonidine; Cyclic AMP; In Vitro Techniques; Male; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2

1995
Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Agmatine; Animals; Body Water; Brimonidine Tartrate; Dose-Response Relationship, Drug; Gastrointestinal Motility; Imidazoles; Male; Peristalsis; Quinolines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Vasoactive Intestinal Peptide; Yohimbine

1997
Agmatine induces glutamate release and cell death in cultured rat cerebellar granule neurons.
    Brain research, 2003, Nov-14, Volume: 990, Issue:1-2

    Topics: Agmatine; Animals; Botulinum Toxins; Cell Death; Cell Survival; Cells, Cultured; Cerebellum; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; L-Lactate Dehydrogenase; Neurons; Potassium; Quinoxalines; Rats; Tetrazolium Salts; Thiazoles

2003
Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Annals of the New York Academy of Sciences, 2003, Volume: 1009

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Agmatine; Animals; Benzofurans; Bridged Bicyclo Compounds; Brimonidine Tartrate; Drug Synergism; Heart; Heptanes; Imidazoles; Imidazoline Receptors; Norepinephrine; Oxazoles; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Sympathetic Nervous System; Sympatholytics; Yohimbine

2003
Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:6

    Topics: Agmatine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Female; Glycogen Synthase Kinase 3; Hindlimb Suspension; Mice; Motor Activity; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Receptor, trkB; Receptors, AMPA; Signal Transduction; TOR Serine-Threonine Kinases

2016